Clinical Trial Update: Prospective Cohort of Immune Checkpoint Inhibitor-induced Hepatitis

View source ↗

Summary

A prospective cohort study investigating immune checkpoint inhibitor–induced hepatitis in cancer patients; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Hepatitis A

Snippet

Sponsor: University Hospital, Montpellier | Conditions: Liver Injury, Secondary to Immune Checkpoint Inhibitors | Status: RECRUITING